SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 84 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $3,820,000 | +1.4% | 6,974,854 | 0.0% | 0.29% | -1.0% |
Q1 2016 | $3,766,000 | -39.8% | 6,974,854 | 0.0% | 0.29% | -16.1% |
Q4 2015 | $6,260,000 | +10.8% | 6,974,854 | 0.0% | 0.35% | +27.9% |
Q3 2015 | $5,650,000 | +107.1% | 6,974,854 | +669.6% | 0.27% | +124.8% |
Q2 2015 | $2,728,000 | +84.6% | 906,263 | +50.2% | 0.12% | +65.8% |
Q1 2015 | $1,478,000 | – | 603,400 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |